semaglutide oral cardiovascular indication 2025 news outcomes align more closely with attained dose than achieved weight loss SELECT: Semaglutide's Impact on CVD

Notably, CT-388's weight loss curve had not plateaued at 48 weeks, suggesting the final treatment effect could be even higher at 72 weeks in the Phase III program

Most people experiencing chronic stress, low energy, inflammation, or toxin exposure can benefit from additional glutathione support

Both are also shown to have an added benefit of promoting weight loss

There is the possibility that the cause of a persons gastroparesis will remain unknown

We should also look at what is being done to raise awareness and ensure better diagnosis and treatment for people with Pernicious Anaemia and B12 deficiency from other causes

They are even still doing compounded tirzepatide and giving it off label to kids